A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Clinical trial NCT06504147 · RECRUITING
Trial details
- NCT number
- NCT06504147
- Sponsor
- Oncoinvent Solutions AS
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-15
- Primary completion
- 2028-02-29
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.